Zimmer files FDA 510(k) for Monogram knee robot, eyes 2027 launch
Zimmer has handed the FDA its 510(k) submission for the Monogram knee robot it bought in 2025 for $177 million, with a 2027 launch now in sight — a year ahead of schedule. Surgeon feedback at a Stifel conference pointed to time savings, fewer instrument trays and better accuracy, though Tornos warned the review could see back and forth.
- Original source: medtechdive.com.
- The source published it on Nov 20, 2026 at 3:47 AM.
- No second outlet has reported it yet. Treat it as a single-source claim.
Zimmer has filed a 510(k) with the FDA for the surgical robot it picked up through its 2025 acquisition of Monogram Technologies, a deal worth $177 million. The submission runs on a 90-day review clock, and Zimmer is now targeting a 2027 launch — a year earlier than the 2028 timeline it had originally planned.
When Zimmer bought Monogram, the company came with a semi-autonomous robot already used in total knee replacements. Monogram was also developing a fully autonomous version designed to work hands-free, steered by foot pedals. The robot separates itself from Zimmer's existing orthopedic system, Rosa, because it can be used alongside CT imaging.
Monogram's clinical trial produced no safety events, according to Tornos, and the robot delivered faster bone preparation and landmarking before procedures. Tornos also flagged that the FDA review may not run in a straight line. “I wouldn't be surprised if there's some back and forth with the FDA, given that this is new-to-the-world technology,” Tornos said.
Two orthopedic surgeons got a look at the robot at a Stifel conference on Sunday, and came away pointing to meaningful time savings, less use of instrument trays and better accuracy, Stifel analyst Rick Wise wrote in a research note. The surgeons added that automated bone cutting could ease the physical strain procedures put on their bodies.
TopicsZimmer · Monogram Technologies · FDA · Rosa · Tornos · Rick Wise · Stifel
Source: medtechdive.com
Written by AI from verified reporting.
More stories
- Health & science finance.yahoo.com 0 viewsFDA clears Novo's once-weekly Sogroya for kids with Turner Syndrome
- Health & science phys.org Caught by @boxlink 1 viewYale team catches excitons acting like light in a one-atom-thick material
- Health & science wisbusiness.com 1 viewUW Alzheimer's tau tracer wins FDA approval after 2,200 scans
- Health & science hoodline.com 1 viewShionogi Snags Biotech Startup in Massive $2 Billion Rare Disease Power Play

